India's first COVID-19 vaccine Covaxin: From trials to test results — key updates
A 30-year-old man took the first dose of COVID-19 vaccine candidate at Delhi's AIIMS last week
At least 375 people will participate in the first phases of clinical human trial of India's first COVID-19 vaccine
As the coronavirus cases top 1.6 crore globally, the scientists are leaving no stone unturned to develop a vaccine. Covaxin, India's first indigenous vaccine against the novel COVID-19, has already started its clinical human trial across the country. Developed by Bharat Biotech International Limited along with Indian Council of Medical Research and National Institute of Virology, Covaxin was the first COVID-19 vaccine candidate to get an approval from Drug Controller General of India (DCGI) in India.